Lung Cancer Webinars
Bringing experiences together
Welcome to the Siemens Healthineers Lung Cancer Webinar series, designed to provide healthcare professionals, researchers, and patients with the latest information and insights on lung cancer screening, diagnosis and treatment. Our webinars feature leading experts in the field of oncology who share their perspectives on the latest advancements in lung cancer.
Cancer Care Day 2024
Interdisciplinary perspectives in Lung Cancer: advancements in screening modalities and surgical implications
View the recording of our symposium on lung cancer management, in which advanced screening techniques impact surgical strategies. Radiology and surgery experts present innovative approaches to refine clinical decisions and enhance patient outcomes. Explore diagnostic modalities and surgical interventions designed to maximize precision in lung cancer treatment.
- PD Dr. med. Isabelle Ayx, Consultant Radiologist, Scientific Head of the Center of Cardiovascular Imaging at the University Medical Centre Mannheim: "Unpacking Lung Cancer Screening - The Why and How".
- Prof. Nicola Sverzellati, Professor of Radiology at the Department of Medicine and Surgery, University of Parma, Italy: “What to know about your Lung-RADS score?”
- Prof. Dr. Isabelle Opitz, Director of the Clinic for Thoracic Surgery at the University Hospital Zurich: "New frontiers in thoracic surgery – Implications of lung cancer screening on surgical therapy”
- Explore the morbidity and mortality of lung cancer worldwide.
- Understand the benefits, risks, and risk-based inclusion criteria associated with lung cancer screening (LCS).
- Familiarize yourself with the Lung-RADS 2022 categories, the management of nodules, and the implications of early detection on thoracic surgery.
AI in Clinical Pathways
Advancing Lung Cancer Care: AI in Clinical Pathways, Screening Programs, and Multidisciplinary Teamwork
Journey into the forefront of lung cancer care with Dr. Isabelle Ayx, Consultant Radiologist and Scientific Head of the Centre of Cardiovascular Imaging at the University Medical Centre Mannheim. In this interview, explore the integration of artificial intelligence (AI) into lung cancer care pathways. Dr. Ayx discusses the potential benefits and challenges of AI support for reading and reporting, sheds light on the current status of lung cancer screening programs in Germany and emphasizes the pivotal role of multidisciplinary teamwork in conquering lung cancer.
- Gain insight into the advantages of AI integration in lung cancer care, benefiting patients, clinicians, and the healthcare system.
- Evaluate the challenges and requirements associated with implementing AI support for reading and reporting in lung cancer screening programs.
- Recognize the indispensable role of multidisciplinary teamwork in optimizing lung cancer care pathways and enhancing patient outcomes.
Role of Imaging and Multidisciplinary Collaboration
Enhancing Thoracic Surgery and Treatment Approaches for Lung Cancer: The Role of Imaging and Multidisciplinary Collaboration
Embark on a journey of innovation in thoracic surgery and treatment approaches for lung cancer with Prof. Dr. Isabelle Opitz, Director of the Clinic for Thoracic Surgery at the University Hospital Zurich. In this interview, Prof. Opitz sheds light on the impact of lung cancer screening programs on early detection and treatment. Explore the role of minimal invasive techniques in thoracic surgery and the significance of multidisciplinary collaboration in optimizing patient care.
- Understand the significance of lung cancer screening programs in detecting the disease at earlier stages and their impact on treatment approaches, particularly in thoracic surgery.
- Explore advanced minimal invasive techniques such as video-assisted thoracoscopic surgery and robotic techniques in thoracic surgery for lung cancer.
- Recognize the crucial role of multidisciplinary collaboration in interpreting imaging, determining optimal diagnostic and treatment approaches, and advancing new techniques for lung cancer treatment.
Optimizing Lung Cancer Screening
Optimizing Lung Cancer Screening: Tin Filter Advantages, Italian Program Status, and Multidisciplinary Collaboration
Dive deep into the optimization of lung cancer screening with Prof. Nicola Sverzellati, Professor of Radiology at the University of Parma, Italy. In this interview, explore the advantages of Tin Filter in lung cancer screening CT assessment and gain insights into the status of lung cancer screening programs in Italy. Prof. Sverzellati underscores the critical role of multidisciplinary collaboration in effectively diagnosing and treating lung cancer.
- Understand the added value of Tin Filter in lung cancer screening CT assessment, including its ability to reduce radiation dose while maintaining image quality and characterizing various types of nodules.
- Evaluate the status of lung cancer screening programs in Italy, including the development of national networks and challenges in implementation and requirements.
- Recognize the importance of multidisciplinary teamwork in effectively diagnosing and treating lung cancer, and the potential role of industry support in enhancing early diagnosis and therapeutic options through integrated imaging technology and therapeutic advancements.
Rozemarijn Vliegenthart: Early detection of diseases in Low dose chest CT beyond Lung cancer: Why and how?
Join Professor Rozemarijn Vliegenthart, radiologist and professor of cardiothoracic imaging at the Data Science Center in Health, Universitair Medisch Centrum Groningen, The Netherlands, as she explores the expanding role of low-dose chest CT beyond lung cancer screening. Discover how these scans provide insight into degenerative diseases such as coronary artery disease and chronic obstructive pulmonary disease, paving the way for early intervention. Delve into the ongoing debate about the interpretation of early CT signs and the critical role of AI software in this process.
- Understand the potential of low-dose chest CT to detect degenerative disease beyond lung nodules.
- Recognize the importance of early detection in improving outcomes for conditions such as coronary artery disease and chronic obstructive pulmonary disease.
- Explore the evolving landscape of radiology practice, including the use of AI software for imaging biomarkers and management of incidental findings.
Video Archive
ECR 2023
Cancer Day
Lung screening – from clinical studies to established programs
In this video, the panel of experts will share their insights and perspectives on the current status of lung cancer screening, including the latest advancements in technology, best practices for patient selection, and ongoing research efforts.
Agenda
- Sebastian Schmidt, Senior Manager for Medical Affairs at Siemens Healthineers Forchheim
“ Update on lung screening in Europe” - Ante Marušić, MD, PhD, LCS Team, Zagreb, Croatia
“Three years after the first lung screening: experience sharing from Croatia” - Rozemarijn Vliegenthart, MD, PhD, Professor of Radiology at the University of Groningen, the Netherlands
“Lung screening: current challenges and solutions” - Felix Herth, MD, PhD, Professor of Internal Medicine and Pulmonology at the University of Heidelberg, Germany
“The role of pulmonology in lung cancer screening”
Learning Objectives
- To understand the status of lung cancer screening programs in the EU
- To learn which steps are to be considered in setting up a lung screening program
- To understand the learnings in setting up a lung screening program
- To learn how AI can be used in lung screening
- To understand the role of pulmonology in the lung cancer screening process
ECR panel discussion
What can the radiology community do to drive lung screening in Europe?
On Wednesday, March 1, from 17:00 to 17:30, an online panel discussion took place to address the recent recommendation by the EU council to extend screening programs to lung cancer. Lung screening programs have been established in many European countries, but their implementation and effectiveness vary due to differences in healthcare systems per country. The panel discussed topics such as the importance of screening, the current state of lung screening programs, the role of radiologists in driving lung screening in their respective countries and the use of AI in lung screening.
Agenda
- Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers, Germany
- Prof. Marie Pierre Revel, Head of Radiology department at Cochin hospital, France
- Prof. Dr. med. Hans-Ulrich Kauczor, Head of clinic for diagnostic and interventional radiology at Heidelberg University Hospital, Germany
- Mélisande Rouger, ESR moderator
Learning Objectives
- To understand the main benefit of AI in lung cancer screening
- To evaluate the importance of lung screening and the role of radiologists in driving its implementation
- To analyze the potential and challenges of using AI in lung cancer screening
AI in Lung Screening
The use of AI in lung cancer diagnosis
Prof. Grenier is a leading expert in radiology and imaging, with a particular focus on lung cancer screening. He is currently working at Hôpital Foch in Suresnes, France, where his research focuses on improving medical imaging techniques and protocols for the early detection of lung cancer. With the advent of AI and machine learning technologies, Prof. Grenier has been exploring their potential applications in lung screening to improve accuracy, efficiency, and ultimately patient outcomes. His work contributes to advancing our understanding of how AI can be used to enhance medical imaging and improve patient outcomes in lung cancer screening.
Learning Objectives
- To understand how AI can improve lung cancer screening by analyzing medical imaging data
- To identify non-oncological factors that should be considered when performing lung cancer screening
Experience Sharing
Lung Cancer Screening in Europe
The life-saving potential of early lung cancer detection1 is increasingly recognized, and individual countries have already started to implement screening programs.
What can we learn from these countries?
Target group: Medical (e.g., radiologists, pulmonologists, and other referral and specialty physicians) and policy stakeholders
Agenda
- General considerations: Steps towards the implementation of lung cancer screening programs at European level (Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers)
- Lung cancer screening in the UK: Experiences and insights in a trailer-based program (Professor Richard Booton2 PhD FRCP, Consultant Respiratory Physician, Honorary MAHSC Clinical Professor & Clinical Director, Directorate of Lung Cancer & Thoracic Surgery, North West Lung Centre, Wythenshawe Hospital, Manchester, UK)
- Lung cancer screening in Poland: Organizational program set-up (Joanna Bidzińska2, Ph.D., EMBA, Project coordinator of National Lung Cancer Screening in the University Clinical Centre in Gdańsk for the northern Macroregion of Poland)
- Q&A
Learning Objectives
- Why is lung cancer screening a critical factor in reducing lung cancer mortality?
- What is the status of lung cancer screening programs in the EU?
- How can a screening program be implemented?
- What are possible approaches on how to set up a lung cancer screening program?
- What are the lessons or pitfalls?
ECR 2022
Focus on Radiology: Lung cancer screening and its role in radiology practice
At ECR 2022, we held our lunch symposium titled "Lung cancer screening and its role in radiology practice", which was very well received.
Agenda
- Experience with the implementation of LCS in Poland: How Poland set up their lung cancer screening program, Radiologist and lung cancer screening. Polish experience (Prof. Witold Rzyman2, Gdansk / Poland)
- CT Technologies for Lung Cancer Screening: Which technology parameters are important to achieve good quality images at ultra low dose, what needs to be considered in finding your local LCS protocol (Prof. Dr. Marc Kachelrieß2, Heidelberg / Germany)
- The role of Artificial Intelligence (AI) in a LCS Program: Identifying smoking-related disease on LCS CT scans, the role of AI in LCS (Prof. Philippe Grenier2, Suresnes, France)
- Q&A
Pomohli vám tieto informácie?
Ďakujeme
https://ers.app.box.com/v/ERS-ESR-Lung-Cancer-Factsheet | Accessed 27.09.2022
Speakers signed a speaker contract